RxDoctor Payments Data

Michael Burnett

Pulmonary Disease · Lansing, MINPI 1730169418

Payments from drug & device makers

$3,389in general payments, 2019–2025

Across 203 payments — averaging $16.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$760
  • AstraZeneca$602
  • Grifols USA, LLC$482
  • GSK$364
  • Mylan Specialty L.p.$198
  • Sanofi$158
  • plus $825 from 20 others

What the payments were for

  • Food & beverage$3,28997%
  • Education$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,389 in reported general payments places this provider in the 60th percentile of 463 pulmonary disease providers in Michigan.

See all pulmonary disease providers in Michigan

Other pulmonary disease in Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →